Encephalopathy and cerebral infarction in OKT3-treated patients with concomitant elevation of cerebrospinal fluid tumour necrosis factor alpha.
Reiss
R
R
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine.
Makoff
D
D
Rodriguez
H
H
Graham
S
S
Mittleman
J
J
Jordan
S
S
D000328:Adult; D000368:Aged; D001927:Brain Diseases / Q000209:etiology*; D002544:Cerebral Infarction / Q000209:etiology*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000009:adverse effects*; D014409:Tumor Necrosis Factor-alpha / Q000134:cerebrospinal fluid*
D016853:Muromonab-CD3; D014409:Tumor Necrosis Factor-alpha